New top team at Takeda UK

17 August 2009

The senior leadership team at Takeda UK has been strengthened by three recent appointments.

Following the move of managing director Trevor Smith Europe in a vice president role responsible for new product optimisation, Yasuhiro (Hiro) Fukutomi has been appointed as his successor.

As the new MD of Takeda UK (one of the highest performing Takeda affiliates), Mr Fukutomi is expected to bring this wide-ranging experience to bear on realizing the full potential of the UK market, building on the company's unique business model to drive sales growth through partnership with healthcare providers in line with the principles of Takeda-ism.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK